These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 7594106)
41. [Hypertrophic myocardiopathy (I). The clinical and echocardiographic characteristics of a population of 72 patients]. de la Morena G; Ruipérez JA; García García J; Salas J; Jaén E; López Candel J Rev Esp Cardiol; 1991 Jan; 44(1):11-7. PubMed ID: 1871402 [TBL] [Abstract][Full Text] [Related]
43. Distribution of hypertrophy in obstructive and non-obstructive types of hypertrophic cardiomyopathy. Gregor P; Widimský P; Cervenka V; Sládková T; Vísek V Cor Vasa; 1984; 26(4):275-80. PubMed ID: 6541554 [TBL] [Abstract][Full Text] [Related]
44. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients > or = 65 years of age. Lewis JF; Maron BJ Am J Cardiol; 1994 Jun; 73(15):1105-11. PubMed ID: 8198038 [TBL] [Abstract][Full Text] [Related]
45. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Maron BJ; Bonow RO; Seshagiri TN; Roberts WC; Epstein SE Am J Cardiol; 1982 Jun; 49(8):1838-48. PubMed ID: 6211078 [TBL] [Abstract][Full Text] [Related]
46. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. Maron BJ; Spirito P; Wesley Y; Arce J N Engl J Med; 1986 Sep; 315(10):610-4. PubMed ID: 2942774 [TBL] [Abstract][Full Text] [Related]
47. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Wigle ED; Sasson Z; Henderson MA; Ruddy TD; Fulop J; Rakowski H; Williams WG Prog Cardiovasc Dis; 1985; 28(1):1-83. PubMed ID: 3160067 [TBL] [Abstract][Full Text] [Related]
48. [Echocardiographic criteria of asymmetrical hypertrophy of the ventricular septum without outflow tract obstruction (author's transl)]. Schweizer P; Hanrath P; Bleifeld W; Effert S Dtsch Med Wochenschr; 1975 Oct; 100(43):2189-93. PubMed ID: 1236787 [TBL] [Abstract][Full Text] [Related]
49. Relative effects of left ventricular mass and conduction disturbance on activation in patients with pathological left ventricular hypertrophy. Xiao HB; Brecker SJ; Gibson DG Br Heart J; 1994 Jun; 71(6):548-53. PubMed ID: 8043336 [TBL] [Abstract][Full Text] [Related]
51. [Hypertrophic cardiomyopathy--diagnostic significance of the disproportion of myocardial hypertrophy examined by two-dimensional echocardiography]. Tomov I; Kutova Ts; Turnovska R Vutr Boles; 1988; 27(3):41-7. PubMed ID: 2974670 [TBL] [Abstract][Full Text] [Related]
52. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002 [TBL] [Abstract][Full Text] [Related]
53. [Hypertrophic cardiomyopathy: distribution of the hypertrophy evaluated by bidimensional echocardiography and observations on the genesis of the obstruction]. Lazzeroni E; Domenicucci S; Das S; ten Cate F; Roelandt J G Ital Cardiol; 1984 Jun; 14(6):418-23. PubMed ID: 6541170 [TBL] [Abstract][Full Text] [Related]
54. [The role of magnetic resonance in studying hypertrophic cardiomyopathy: the echocardiographic correlations and clinical implications]. Rapezzi C; Fattori R; Castriota F; Passarelli P; Magnani G; Galiè N; Ferlito M; Bertaccini P; Branzi A; Gavelli G Cardiologia; 1994 Jan; 39(1):7-15. PubMed ID: 8020058 [TBL] [Abstract][Full Text] [Related]
55. Unusual distribution of left ventricular hypertrophy in obstructive hypertrophic cardiomyopathy: localized posterobasal free wall thickening in two patients. Maron BJ; Spirito P; Chiarella F; Vecchio C J Am Coll Cardiol; 1985 Jun; 5(6):1474-7. PubMed ID: 3158691 [TBL] [Abstract][Full Text] [Related]
56. [Diastolic filling of the right ventricle in hypertrophic cardiomyopathy studied with 2-dimensional Doppler echocardiography]. Okamoto M; Kinoshita N; Miyatake K; Nagata S; Beppu S; Park YD; Pyon ZF; Sakakibara H; Nimura Y J Cardiogr; 1983 Mar; 13(1):79-88. PubMed ID: 6685744 [TBL] [Abstract][Full Text] [Related]
57. Severe left ventricular wall thinning and extensive fibrosis without evolution to end stage disease in a patient with hypertrophic cardiomyopathy. Assenza GE; Spirito P; Musumeci MB; Lombardi M; Quarta G; Autore C J Am Soc Echocardiogr; 2009 Oct; 22(10):1196.e1-2. PubMed ID: 19801310 [TBL] [Abstract][Full Text] [Related]
58. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy. Paz R; Jortner R; Tunick PA; Sclarovsky S; Eilat B; Perez JL; Kronzon I N Engl J Med; 1996 Sep; 335(13):938-41. PubMed ID: 8782501 [TBL] [Abstract][Full Text] [Related]
59. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Maron BJ; Tajik AJ; Ruttenberg HD; Graham TP; Atwood GF; Victorica BE; Lie JT; Roberts WC Circulation; 1982 Jan; 65(1):7-17. PubMed ID: 6458422 [TBL] [Abstract][Full Text] [Related]
60. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Pons-Lladó G; Carreras F; Borrás X; Palmer J; Llauger J; Bayés de Luna A Am J Cardiol; 1997 Jun; 79(12):1651-6. PubMed ID: 9202357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]